Fusion event
HBV-chr15 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGC| |TGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTG
End
39150040/38857839 (Hg38)
Nearest miRNA
hsa-mir-1233-1/Upstream/1884938; hsa-mir-10393/Downstream/2833746;
Upstream sequence
GCTTTGGATGTAGATTTTAGAAATGAATCAACCGTTGTACAGTTTTGTTTCCCATCTCTTGCTATGCAGGCCAGTGTTATAAGTTTGATGCAGCTGAAGA
Downstream sequence
TGGTAGTGTTAGTTGGTGGCCCTTCAGAGATAATTCTTATGTCCCATCCCATGGAAGATAGAGAAGTATGGGAGATAAAACTGTGGGCTCTTTCTTCCCT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.